Terumo announced today that it initiated a voluntary recall of specific models of its Relay Pro thoracic stent graft system.

Terumo has yet to establish a direct causal relationship between the deaths and the delivery system separation issues.

The NEW DuraPulse™ Stent/Graft test (SGT) instrument extends the performance and reliability that ElectroForce SGTs have become known for over the past 20 years. Still utilizing proprietary ...

Endovascular repair -- fixing an injury in a blood vessel from inside that vessel -- is a better option for individuals who receive highly lethal injuries from high-speed collisions or falls (together ...

Unused Valiant Navion thoracic stent grafts are being voluntarily recalled by the manufacturer, Medtronic, following reports that three patients who participated in the Valiant Evo global clinical ...

A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...

An increasing number of patients with thoracic aortic aneurysms are being treated with a device called a stent graft, rather than open-chest surgery. The device is delivered with a cathether. Patients ...

Featuring a unique, patented, sealing technology, the ALTO Abdominal Stent Graft System is the latest generation of innovative therapies for AAA patients. ALTO utilizes a low-profile delivery system ...

Stent–graft placement is used to treat aneurysms of the abdominal aorta. Weakening of the wall of the aorta can lead to widening of the vessel, or aneurysm. Aneurysms may rupture causing internal ...

NEW YORK, Oct. 2, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The Global Aortic Stent Grafts Market size is estimated to grow by USD 659.2 million from 2024-2028, ...